ferric chloride has been researched along with Brain Embolism and Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, G; Gerriets, T; Heil, M; Kaps, M; Madlener, K; Röttger, C; Stolz, E; Walberer, M; Wessels, T | 1 |
| Liu, XG; Xu, LN | 1 |
2 other study(ies) available for ferric chloride and Brain Embolism and Thrombosis
| Article | Year |
|---|---|
Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Topics: Abciximab; Angiography; Animals; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Chlorides; Disease Models, Animal; Edema; Enoxaparin; Ferric Compounds; Heparin; Humans; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Intracranial Embolism and Thrombosis; Magnetic Resonance Imaging; Male; Rats; Recombinant Proteins; Sagittal Sinus Thrombosis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2005 |
[A rat middle cerebral artery thrombosis model for evaluation of thrombolytic and antithrombotic agents].
Topics: Animals; Aspirin; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Male; Rats; Rats, Wistar; Urokinase-Type Plasminogen Activator | 1995 |